Works matching AU Awolade, Paul

Results: 11

CHD1L in cancer and beyond: structure, oncogenic functions, and therapeutic potential.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2025, v. 44, n. 1, p. 1, doi. 10.1186/s13046-025-03428-1

By:

Clune, Sophia;
Awolade, Paul;
Esquer, Hector;
Zhou, Qiong;
LaBarbera, Daniel V.

Publication type:

Article

Synthesis,Antidiabetic and Antitubercular Evaluation of Quinoline–pyrazolopyrimidine hybrids and Quinoline‐4‐Arylamines.

Published in:

ChemistryOpen, 2024, v. 13, n. 9, p. 1, doi. 10.1002/open.202400014

By:

Cele, Nosipho;
Awolade, Paul;
Seboletswe, Pule;
Khubone, Lungisani;
Olofinsan, Kolawole;
Islam, Md. Shahidul;
Jordaan, Audrey;
Warner, Digby F.;
Singh, Parvesh

Publication type:

Article

New library of pyrazole–imidazo[1,2‐α]pyridine molecular conjugates: Synthesis, antibacterial activity and molecular docking studies.

Published in:

Chemical Biology & Drug Design, 2020, v. 95, n. 1, p. 162, doi. 10.1111/cbdd.13632

By:

Ebenezer, Oluwakemi;
Awolade, Paul;
Koorbanally, Neil;
Singh, Parvesh

Publication type:

Article

Synthesis and Antimicrobial Evaluation of 1H-1,2,3-Triazole-Linked Quinoline-Phenolic Natural Product Conjugates.

Published in:

Polycyclic Aromatic Compounds, 2025, v. 45, n. 1, p. 19, doi. 10.1080/10406638.2024.2380996

By:

Awolade, Paul;
Seboletswe, Pule;
Singh, Parvesh

Publication type:

Article

Quinoline–1,3,4-Oxadiazole Conjugates: Synthesis, Anticancer Evaluation, and Molecular Modelling Studies.

Published in:

Polycyclic Aromatic Compounds, 2023, v. 43, n. 7, p. 6437, doi. 10.1080/10406638.2022.2117205

By:

Cele, Nosipho;
Awolade, Paul;
Dhawan, Sanjeev;
Khubone, Lungisani;
Raza, Asif;
Sharma, Arun K.;
Singh, Parvesh

Publication type:

Article

α-Glucosidase and α-Amylase Inhibitory Potentials of Quinoline–1,3,4-oxadiazole Conjugates Bearing 1,2,3-Triazole with Antioxidant Activity, Kinetic Studies, and Computational Validation.

Published in:

Pharmaceuticals (14248247), 2022, v. 15, n. 8, p. 1035, doi. 10.3390/ph15081035

By:

Cele, Nosipho;
Awolade, Paul;
Seboletswe, Pule;
Olofinsan, Kolawole;
Islam, Md. Shahidul;
Singh, Parvesh

Publication type:

Article

CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models.

Published in:

International Journal of Molecular Sciences, 2024, v. 25, n. 23, p. 13160, doi. 10.3390/ijms252313160

By:

Sala, Rita;
Esquer, Hector;
Kellett, Timothy;
Clune, Sophia;
Awolade, Paul;
Pike, Laura A.;
Zhou, Qiong;
Messersmith, Wells A.;
LaBarbera, Daniel V.

Publication type:

Article

CHD1L Regulates Cell Survival in Breast Cancer and Its Inhibition by OTI-611 Impedes the DNA Damage Response and Induces PARthanatos.

Published in:

International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 8590, doi. 10.3390/ijms25168590

By:

Sala, Rita;
Esquer, Hector;
Kellett, Timothy;
Kearns, Jeffrey T.;
Awolade, Paul;
Zhou, Qiong;
LaBarbera, Daniel V.

Publication type:

Article

Synthesis, antimicrobial evaluation, and in silico studies of quinoline—1H-1,2,3-triazole molecular hybrids.

Published in:

Molecular Diversity, 2021, v. 25, n. 4, p. 2201, doi. 10.1007/s11030-020-10112-3

By:

Awolade, Paul;
Cele, Nosipho;
Kerru, Nagaraju;
Singh, Parvesh

Publication type:

Article

Synthesis, Cytotoxicity and Antimicrobial Evaluation of New Coumarin‐Tagged β‐Lactam Triazole Hybrid.

Published in:

Chemistry & Biodiversity, 2020, v. 17, n. 1, p. N.PAG, doi. 10.1002/cbdv.201900462

By:

Dhawan, Sanjeev;
Awolade, Paul;
Kisten, Prishani;
Cele, Nosipho;
Pillay, Ashona‐Singh;
Saha, SouravTaru;
Kaur, Mandeep;
Jonnalagadda, Sreekantha B.;
Singh, Parvesh

Publication type:

Article

Recent Developments on the Synthesis and Biological Activities of Fused Pyrimidinone Derivatives.

Published in:

ChemMedChem, 2021, v. 16, n. 13, p. 2050, doi. 10.1002/cmdc.202100083

By:

Seboletswe, Pule;
Awolade, Paul;
Singh, Parvesh

Publication type:

Article